Gérard Le Fur

Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.

eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France.

French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France.

eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation.

Compas SA wholesales chemical products. The company was founded on April, 19 1949 and is headquartered in Gueux, France.

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.